Turbo Cancers on the Rise: Yale experts

By Editorial Team -
A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way.

 

Dr. Harvey Risch first reported in September 2023 that Clinicians at Yale Medical School were seeing some new cancer situations in adults as young as 25, with no family history of developing colorectal cancer, suddenly developing highly aggressive forms of the disease. So aggressive that between diagnosis and first treatment, the cancers have grown dramatically (1). This phenomenon has rapidly accelerated since the Pandemic.

These ‘turbo cancers’ do not conform to the normal behaviour of cancers, not only are they more aggressive, but there seem to be more genetic issues in these cancers.

Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine.

 

In 2022 there was a report in Nature (2) from researchers at Harvard, amongst others referring to increases in young cancer, often described as Early Onset Cancer. Yale Researchers believe early onset cancer has gone turbo since the pandemic.

 

The CEO of the American Cancer Society described the report as “a call to arms.”

Doctor Jeremy Kortmansky and Doctor Mariya Rozenblit of Yale Medicine have observed that younger adults tend to have more aggressive-appearing cancers compared to older adults. And, so far, this difference is seen in various cancer types, including colorectal, gastric and oesophageal cancers and breast cancer. In fact, Yale Cancer Center has now developed an ‘Early Onset Cancer Program’ to focus on patients with these aggressive cancers and diagnosed between the ages of 18-49. They have done this in partnership with the Smilow Cancer Hospital, a leading comprehensive cancer center in Connecticut, affiliated with the Yale Cancer Center.

 

Dr Veda Giri is the newly appointed director in charge of Yale Cancer Center and Smillow’s Early Onset Program. When Dr. Giri surveyed Smilow’s patient records from the last two years, she discovered approximately 1,300 cases of early onset breast cancer, about 600 cases of early onset gastrointestinal cancers, and close to another thousand cases across other cancer types. These new figures came as a shock. “It’s a real issue that has to be prioritized,” Giri stated.

 

But it’s not just the aggression of these cancers; the genetic issues mean that drugs may not currently exist to treat these cancers. Then younger patients may also have young families, may have more financial issues and may worry more about fertility.

Turbo cancers and repurposed drugs: Dr William Makis and Dr John Campbell (YouTube 2025)

 

Studies and Case Reports of Cancer Following COVID-19 Vaccination?

Studies and case reports of various cancers following mRNA vaccination are helping experts understand the potential mechanisms that may be allowing these cancers to proliferate.

In a 2023 Belgian study published in Frontiers Oncology, researchers presented the first case of malignant lymphoma in mice. Malignant lymphoma is a rare adverse event reported following mRNA COVID-19 vaccination.

Two days after receiving a booster dose of Pfizer’s COVID-19 vaccine, one of 14 mice suffered spontaneous death. Upon examination, the 14-week-old mouse had abnormally large organs and cancerous lymphoma in the liver, kidneys, spleen, heart, and lungs. Although showing direct causality is complex, the authors said their findings add to “previous clinical reports on malignant lymphoma development following novel mRNA COVID-19 vaccination.”

In a January 2023 paper in Medicina, researchers presented the case of a 66-year-old man who developed swollen lymph nodes 10 days after receiving his third dose of Pfizer. After further testing, the patient was diagnosed with stage 2 non-Hodgkin lymphoma (NHL). A literature review found eight additional cases of NHL that developed shortly after COVID-19 vaccination. Five lymphoma cases occurred after vaccination with Pfizer, one case after vaccination with AstraZeneca, one after the Johnson & Johnson shot, and one after vaccination with Moderna.

In an August 2022 Letter to the Editor in the Journal of the European Academy of Dermatology & Venereology, physicians described two patients diagnosed with diffuse large B-cell lymphoma that developed from swollen lymph nodes following vaccination with Pfizer’s COVID-19 vaccine.

The study’s authors found that diffuse large B-cell lymphoma “may rapidly grow” after vaccination with Pfizer’s COVID-19 vaccine and urged dermatologists to pay attention to swollen lymph nodes or masses near the injection site.

Swollen lymph nodes, or lymphadenopathy, is considered a common side effect of COVID-19 vaccination, more often observed following immunization with novel COVID-19 mRNA vaccines than other vaccines.

Lymphadenopathy is also an acknowledged “non-serious” adverse event of COVID-19 vaccination listed in the U.S. Food and Drug Administration’s (FDA) fact sheets for health care providers for both Moderna and Pfizer’s monovalent and bivalent vaccines. However, pharmaceutical companies and U.S. regulatory agencies have not assessed whether there’s a link between vaccine-related lymphadenopathy and cancer.

Urgent Need to Determine Underlying Causes of Turbo Cancers - Dr.William Makis 

In a September 22, 2023, Highwire interview (video below), Canadian oncologist and cancer researcher Dr. William Makis discussed the alarming rise in post-jab "turbo cancers," a term coined to describe incredibly rapid-growing cancers in people who have received one or more COVID jabs.
 

The exact mechanism giving rise to turbo cancers is unknown, and it’s unclear whether one or multiple mechanisms are responsible for these cancers, Dr. William Makis, an oncologist, cancer researcher, and nuclear medicine radiologist, told The Epoch Times in an email.

Dr. Makis provided the following several possible hypotheses for how mRNA COVID-19 vaccines could cause turbo cancers:

1. The current COVID-19 mRNA vaccines contain pseudouridine-modified mRNA, which attenuates or alters the activity of key proteins in the innate immune system, impairing cancer surveillance.

When activated, these key proteins, called toll-like receptors, can prevent tumors from forming and growing.

2. Vaccination alters T-cell signaling that induces profound impairment in type 1 interferon and cancer surveillance.

T-cells, a type of white blood cell, help the body’s immune system prevent cancer. Studies show that getting multiple shots increases the level of a particular antibody called IgG4, causing T-cell and interferon suppression, leading to an inability to keep cancer in check, Dr. Cole told The Epoch Times.

“Everyone gets atypical cells in their body every day, and having a surveillance system is important, but when the surveillance system is shut off, that allows these cells to go haywire. How long it stays suppressed, nobody knows, and these are the studies NIH (the National Institutes of Health) should have been doing,” said Dr. Cole.

3. The shift of the antibody IgG4 caused by repeated mRNA vaccination could create a tolerance for spike protein and impair the production of the antibodies IgG1 and IgG3 and cancer surveillance.

4. The spike protein produced by the body after COVID-19 mRNA vaccination may interfere with important tumor suppressor proteins—P53, BRCA 1, and two tumor suppressor genes.

5. The spike protein may interfere with DNA repair mechanisms.

6. The RNA from the COVID-19 vaccines may be reverse-transcribed and integrated into the human genome.

7. Pfizer and Moderna vials found to be contaminated with plasmid DNA containing SARS-CoV-2 spike protein may integrate into the human genome.

8. The presence of the simian virus 40 (SV40) in DNA discovered in Pfizer mRNA vaccine vials may lead to cancers—most notably, non-Hodgkin lymphoma and other lymphomas—as it did with SV40-contaminated polio vaccines.

9. mRNA-based vaccines may be triggering the release of oncogenes—oncomiRs or microRNAs, which can enhance or inhibit cancer development and participate in cancer biological processes, such as proliferation, invasion metastasis, angiogenesis, chemoresistance, and immune escape.

“I believe there is an urgent need to determine the underlying mechanisms of turbo cancers because, at this time, oncologists have nothing to offer patients who have developed a turbo cancer, and conventional cancer treatments offer minimal or no benefit,” Dr. Makis told The Epoch Times.

Mr. David Wiseman, a research scientist in pharmacy, pharmacology, and experimental pathology, told The Epoch Times in an email that neither Comirnaty—Pfizer’s fully approved version of its COVID-19 vaccine—nor Spikevax by Moderna has been evaluated for its potential to cause cancer.

On March 30, 2023, Mr. Wiseman and four other experts submitted a 27-page document to the National Academies Committee, an ad hoc committee tasked with reviewing relevant adverse events associated with COVID-19 vaccines.

Using the Vaccine Adverse Event Reporting System (VAERS)—a database co-managed by the U.S. Centers for Disease Control and Prevention (CDC) and FDA used for reporting vaccine adverse events—Mr. Wiseman and his coauthors found an excess of cancer signals for COVID-19 vaccines from Dec. 14, 2020, to July 24, 2023, compared to all other vaccines for all years beginning in 1990.

A safety signal indicates a condition may be linked to a vaccine but requires further analysis to confirm an association.

The findings complemented the CDC’s Proportional Reporting Ratio (PRR) analyses obtained through a Freedom of Information Act (FOIA) request that assessed adverse events reported from Dec. 14, 2020, to July 29, 2022.

A PRR compares reports of specific adverse events experienced after receiving Moderna or Pfizer’s COVID-19 vaccine to those following vaccination with any other vaccine or all non-COVID-19 vaccines. The CDC’s PRR report detected cancer signals for colon cancer, metastatic breast cancer, metastasis to the liver, bones, central nervous system, lymph nodes, breast masses, chronic lymphocytic leukemia, B-cell lymphoma, and follicular lymphoma.

Mr. Wiseman said it’s clear from the FOIA documents that the CDC is aware of cancer reports and isn’t being forthcoming.

“Government agencies knew there were going to be cancers with these shots, and they were trying to cover it up, but the data is trickling out,” Dr. Cole told The Epoch Times, referring to 490 pages of communications obtained from the NIH through a FOIA request.

The CDC is supposed to report on morbidity and mortality—and when a pathologist diagnoses anything, he or she uses a diagnosis code, and it goes to the federal basis that’s reported to federal tracking agencies, Dr. Cole explained.

“All these data subsets should be easy to find if agencies would report what they have,” he said. “We could see statistical changes in diagnosis in the past two and a half years since shots were rolled out. The question is, why are other governments around the world not doing this?”

Case Reports of Turbo Cancer?

Case 1: 34 year old female, a star of "The Bachelorette" was diagnosed with Stage 3 Breast Cancer.

Dr William Makis shared on X/Twitter in March 2025:

TURBO CANCER - 34 year old Katie Thurston, a star of "The Bachelorette" was diagnosed with Stage 3 Breast Cancer. 
She had COVID-19 Vaccines in 2021 and promoted them. Pfizer and Moderna COVID-19 mRNA Vaccines cause Turbo Cancer and Breast cancer is the 2nd most common Turbo Cancer. 
Millions of mRNA Vaccinated women face an elevated breast cancer risk as a result of the jabs, for the rest of their lives. 
Stage 3 Breast cancer in a 34 year old woman? This used to be rare. Sadly, not anymore!
Case 2: 27 year old College Athlete with Stage 4 Colon Cancer to liver

Dr William Makis shared on X/Twitter in March 2025:

IVERMECTIN and FENBENDAZOLE Testimonial - 27 year old College Athlete with Stage 4 Colon Cancer to liver after COVID-19 mRNA Vaccines, has excellent response! I believe we have a 27 year old with Turbo Cancer 27 year old College Athlete developed Stage 4 Colon Cancer after COVID-19 mRNA Vaccines in 2021 (possible Turbo Cancer) Primary tumor was removed but patient has liver metastases. We started on Feb.10, 2025:
  • Ivermectin 1.5mg/kg/day 
  • Fenbendazole 1500mg/day
Oncologist started chemo RESULTS: (after 1 month)
  • CEA 748 to 47.2 (94% drop)
  • CA125 81 to 9 (89% drop)
  • Liver metastasis size: 2.6cm to 2.2cm
“I truly believe your protocol is working wonders for me…” The synergy between chemo + Ivermectin + Fenbendazole can yield stunning results that are shocking Oncologists around the world.


Case 3: 26-year-old with stomach pain diagnosed with stage 4 colon cancer

A 26-year-old with stomach pain diagnosed with stage 4 colon cancer. (Business Insider)


Case 4: 39-year-old woman diagnosed with “vaccination-associated reactive lymphadenopathy” following vaccination (JAMA)

A year after the vaccine rollout, researchers published a case report in the Journal of the American Medical Association (JAMA) of a healthy 39-year-old woman diagnosed with “vaccination-associated reactive lymphadenopathy” following vaccination with Pfizer’s vaccine. Six months later, she was diagnosed with invasive breast cancer in her right breast—the same side of the body where she received her vaccination and experienced swollen lymph nodes.

Got the Jab? Take Action to Safeguard Your Health

If you developed symptoms you didn’t have before your shot, I would encourage you to seek out expert help. In light of the frequency of turbo cancers, postmenopausal women with breakthrough bleeding after their COVID jab would probably be wise to get evaluated to rule out endometrial cancer.

At present, the Front Line COVID-19 Critical Care Alliance (FLCCC) seems to have one of the best treatment protocols for post-jab injuries. It’s called I-RECOVER protocol.


 


Sources and References

 

https://www.canceractive.com/article/yale-experts%20see%20rise%20in%20younger%20turbo%20cancer.

1. The rise of turbo cancer in young people; https://www.theepochtimes.com/epochtv/dr-harvey-risch-rise-in-aggressive-turbo-cancers-and-especially-among-younger-people-atlnow-5489582.
2. Is early-onset cancer an emerging global epidemic? Current evidence and future implications; Ugai, T., Sasamoto, N., Lee, HY. et al. Nat Rev Clin Oncol 19, 656–673 (2022). https://doi.org/10.1038/s41571-022-00672-8.

3. Professor sees vaccines causing cancer - https://www.canceractive.com/article/top-professor%20sees%20vaccines%20causing%20cancer.

4. Ivermectin and Fenbendazole: Treating Turbo Cancer.

Comments

Post a Comment

Popular posts from this blog

Dr Peter McCullough: How to Detox Spike Protein from Body

By Editorial Team -
Image
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body.  I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day Bromelain 500 mg once a day Nano/Liposomal Curcumin 500 mg twice a day Related: Nattokinase, Bromelain and Curcumin from The Wellness Company Additional products can be added, including NAC, IVM (Ivermectin), HCQ (Hydroxychloroquine), fluvoxamine, low-dose naltrexone, and blood thinners, depending on the clinical evaluation and the syndrome. The therapeut...
Read more

How to Remove Spike Protein from Body: FLCCC I-Recover Protocol

By Editorial Team -
Image
Can you remove spike proteins from your body? Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC*, which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a private tele-health practice specializing in the treatment of COVID-19, so-called "long-COVID" and post-vaccine syndrome. *The FLCCC Alliance is now the  Independent Medical Alliance Note that there are significant overlaps between the symptoms and features of long COVID/long-hauler syndrome and post-vaccine syndrome. However, a number of clinical features appear to be characteristic of post-vaccine syndrome; most notably, severe neurological symptoms appear to be more common following vaccination. To c...
Read more

Front Line Doctors Ivermectin Protocol for Prevention and Treatment of COVID-19 (2025)

By Editorial Team -
Image
The Front Line COVID-19 Critical Care (FLCCC*) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate.  *The FLCCC Alliance is now the  Independent Medical Alliance Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the   I-MASK+ protocol   ( is now divided into I-Prevent and I-Care protocols ) for prophylaxis and at home treatment of early stage COVID-19. Quercetin, zinc and a number of nutrients and drugs are part of this protocol, not only for critical care but also for prophylaxis and mild disease being treated at home. This article, we will dive deeper to provide the scientific background, related references and rationale of the FLCCC protocols. FLCCC ( Front Line COVID-19 Critical Care)  Protocols I-MASK+ Prevention & Early Outpatient Treat...
Read more

FLCCC I-Recover Protocol: Post Vaccine Treatment Protocol (2025)

By Editorial Team -
Image
Over the last three years, the COVID-19 pandemic has transformed almost every aspect of our lives before we've had time to stop and question it. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC (The FLCCC Alliance is now the Independent Medical Alliance ), which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a privat...
Read more

Resolving Spike Protein Syndrome – Clearing the Spike from Blood and Cells

By Editorial Team -
Image
BY THOMAS E. LEVY, MD, JD As the acute cases of COVID have continued to decline, the prevalence of the Persistent Spike Protein (PSP) syndrome has continued to increase. The spike protein is that part of the COVID pathogen that attaches to ACE2 receptors throughout the body and permits the entry of the entire virus into the newly infected cell. There appear to be no cells, tissues, or organs in the body that are completely spared from this PSP attack once enough of it has been introduced into the body. The many mechanisms of action involved in the ultimate removal of spike protein. The persistent presence of the spike protein has been shown to be secondary to the inability to completely resolve a bout of COVID (chronic COVID or long-haul COVID) as well as the spike protein exposure from mRNA inoculation(s). And as more time has passed, the PSP syndrome following one or more mRNA shots has emerged as the most common reason for PSP, especially following a booster injection. Not surprisi...
Read more

Find a Doctor to prescribe Hydroxychloroquine, Ivermectin and Early Outpatient Treatments (2025)

By Editorial Team -
Image
Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. 'Early' treatment will make significant difference in outcome as opposed to late treatment.  Related: How can I get Ivermectin? See the directory of professionals in US below. Directory of Doctors (by State) Prescribing Effective Outpatient COVID-19 Therapy USA ​ MULTIPLE STATES (Telemedicine or online consultation) The Wellness Company ( twc.health ) Medical Specialty: Family Medicine, Functional Medicine Supported Protocols: I-PREVENT (COVID Protection), I-CARE (Early at-home treatment), I-RECOVER (Long COVID and Post-Vaccine treatment) Dr. Miguel Antonatos (IVM) (855) 767-8559  https://text2md.com (States: AL, AZ, CO, FL, GA, IA, ID, IL, KS, KY, MD, ME, MI, MN, MS, ND, NE, NJ, NV, OK, SC, SD, TN, UT, VT, WA, WI, WV) ...
Read more

Dr Peter McCullough Early Treatment Protocol

By Editorial Team -
Image
Well-respected North Texas cardiologist, Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough et al. Reviews in Cardiovascular Medicine, 2020 McCullough Protocol 2022 Updates:  How to Detox Spike Protein from Body  (November 2023) Use of hydroxychloroquine in multidrug protocols for SARS-CoV-2 (October 2024) Paxlovid for Vaccinated or Unvaccinated Adult Outpatients with ...
Read more

Dr Peter McCullough's Spike Detox (BSD) Protocol (2025)

By Editorial Team -
Image
Please enjoy this continuing medical education lecture delivered at 40th Cellular Detoxification Conference sponsored by International College of Integrative Medicine in Indianapolis, Indianana, on September 7, 2024. There are no medicine grand rounds or primary care conferences addressing this topic. It is a white space in medicine where no academic medical center has a fundamental approach to handling about 5-10% of the population suffering from post-acute sequalae after recurrent SARS-CoV-2 infection or COVID-19 infection. Both load the body with pathogenic Spike protein which incites inflammation, oxidative stress, coagulation, and all the downstream effects that result in symptoms. BSD=Base Spike Detoxification Because I have taken the ultimate accountability for McCullough Protocol Base Spike Detoxification (BSD) by publishing and copyrighting it in my own name, I can tell you first hand I get feedback about perceived safety and efficacy on a regular basis from all ov...
Read more

FLCCC I-CARE COVID Treatment Protocol for Outpatients (2025 Edition)

By Editorial Team -
Image
Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About I-CARE Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. Updates:  Ivermectin, Hydroxychloroquine Use Soared During COVID-19 Pandemic: 2025 Study 53,000+ Patient Study Finds Low-Dose Hydroxychloroquine Associated with Reduced COVID-19 Mortality in China (Frontiers of Medicine 2025) Note: highlighting his objectivity, while Pi...
Read more

Fact Check: Unpacking the Spike Protein Debate (2025)

By Editorial Team -
Image
Introduction The rapid development and deployment of COVID-19 vaccines have been monumental in combating the global pandemic, saving countless lives and enabling societies to regain a sense of normalcy. Central to the efficacy of many of these vaccines, particularly mRNA and viral vector-based ones, is the spike protein—a key component of the SARS-CoV-2 virus that facilitates its entry into human cells. By instructing the body to produce a version of this protein, vaccines train the immune system to recognize and neutralize the virus without causing illness. However, as vaccination campaigns expanded, so did public curiosity and concern about the spike protein's role, fueled by a mix of scientific complexity, misinformation, and distrust. This article aims to cut through the noise by providing a fact-based exploration of the spike protein in COVID-19 vaccines. Drawing on peer-reviewed studies, expert insights, and data from health authorities, we unpack common claims, clarify the s...
Read more

Labels

Show more